Semnur Pharmaceuticals, Inc. Proceeds from Notes Payable
Semnur Pharmaceuticals, Inc. (SMNR) reported Proceeds from Notes Payable of $170.70 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-22.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2024-11-19
- Semnur Pharmaceuticals, Inc. proceeds from notes payable for the quarter ending 2024-03-31 was $170.70K.
- Semnur Pharmaceuticals, Inc. proceeds from notes payable for the quarter ending 2023-12-31 was $350.00K.
- Semnur Pharmaceuticals, Inc. proceeds from notes payable for the quarter ending 2023-09-30 was $80.00K.
- Semnur Pharmaceuticals, Inc. proceeds from notes payable for the quarter ending 2023-06-30 was $412.50K.
- Semnur Pharmaceuticals, Inc. proceeds from notes payable for fiscal 2023 was $842.50K, a 953.13% increase from fiscal 2022.
- Semnur Pharmaceuticals, Inc. proceeds from notes payable for fiscal 2022 was $80.00K.
| Period end | Proceeds from Notes Payable | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|---|
| 2024-03-31 | $170.70K 10-Q · filed 2024-05-22 | $520.70K derived: sum of 2 quarters · filed 2024-05-22 | $600.70K derived: sum of 3 quarters · filed 2024-05-22 | $1.01M derived: sum of 4 quarters · filed 2024-05-22 | |
| 2023-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $430.00K derived: sum of 2 quarters · filed 2024-04-01 | $842.50K derived: sum of 3 quarters · filed 2024-04-01 | $842.50K 10-K · filed 2024-04-01 | |
| 2023-10-11 | $50.00K 10-Q · filed 2024-11-19 | ||||
| 2023-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $492.50K derived: sum of 2 quarters · filed 2023-11-09 | $492.50K 10-Q · filed 2023-11-09 | $492.50K derived: sum of 4 quarters · filed 2024-04-01 | |
| 2023-07-18 | $492.50K 10-K · filed 2024-04-01 | ||||
| 2023-06-30 | $412.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | $412.50K 10-Q · filed 2023-08-15 | $412.50K derived: sum of 3 quarters · filed 2024-04-01 | $412.50K derived: sum of 4 quarters · filed 2024-04-01 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-15 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $0.00 derived: sum of 4 quarters · filed 2024-04-01 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $0.00 derived: sum of 2 quarters · filed 2024-04-01 | $0.00 derived: sum of 3 quarters · filed 2024-04-01 | $80.00K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $80.00K 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-15 | $80.00K 10-Q · filed 2023-08-15 | |||
| 2022-03-31 | $80.00K 10-Q · filed 2023-05-15 |